nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylnaltrexone—CYP2D6—schizophrenia	0.824	1	CbGaD
Methylnaltrexone—OPRM1—telencephalic ventricle—schizophrenia	0.0146	0.218	CbGeAlD
Methylnaltrexone—OPRK1—forebrain—schizophrenia	0.00538	0.0801	CbGeAlD
Methylnaltrexone—CYP2D6—urine—schizophrenia	0.00536	0.0799	CbGeAlD
Methylnaltrexone—OPRM1—forebrain—schizophrenia	0.00382	0.057	CbGeAlD
Methylnaltrexone—OPRM1—telencephalon—schizophrenia	0.00352	0.0524	CbGeAlD
Methylnaltrexone—OPRK1—nervous system—schizophrenia	0.00292	0.0435	CbGeAlD
Methylnaltrexone—OPRK1—central nervous system—schizophrenia	0.00281	0.0419	CbGeAlD
Methylnaltrexone—CYP2D6—blood plasma—schizophrenia	0.0028	0.0417	CbGeAlD
Methylnaltrexone—OPRK1—cerebellum—schizophrenia	0.00275	0.0409	CbGeAlD
Methylnaltrexone—OPRM1—blood—schizophrenia	0.00256	0.0381	CbGeAlD
Methylnaltrexone—OPRM1—midbrain—schizophrenia	0.00253	0.0376	CbGeAlD
Methylnaltrexone—OPRK1—brain—schizophrenia	0.00223	0.0332	CbGeAlD
Methylnaltrexone—OPRM1—endocrine gland—schizophrenia	0.00222	0.0331	CbGeAlD
Methylnaltrexone—OPRM1—nervous system—schizophrenia	0.00208	0.0309	CbGeAlD
Methylnaltrexone—OPRM1—central nervous system—schizophrenia	0.002	0.0298	CbGeAlD
Methylnaltrexone—OPRM1—brain—schizophrenia	0.00159	0.0236	CbGeAlD
Methylnaltrexone—CYP2D6—forebrain—schizophrenia	0.00153	0.0228	CbGeAlD
Methylnaltrexone—CYP2D6—telencephalon—schizophrenia	0.00141	0.021	CbGeAlD
Methylnaltrexone—Naloxone—ESR1—schizophrenia	0.00113	0.152	CrCbGaD
Methylnaltrexone—CYP2D6—blood—schizophrenia	0.00103	0.0153	CbGeAlD
Methylnaltrexone—Oxymorphone—CYP2D6—schizophrenia	0.000918	0.124	CrCbGaD
Methylnaltrexone—CYP2D6—endocrine gland—schizophrenia	0.000889	0.0133	CbGeAlD
Methylnaltrexone—Buprenorphine—CYP1A2—schizophrenia	0.000874	0.118	CrCbGaD
Methylnaltrexone—CYP2D6—nervous system—schizophrenia	0.000832	0.0124	CbGeAlD
Methylnaltrexone—Hydrocodone—CYP2D6—schizophrenia	0.000803	0.108	CrCbGaD
Methylnaltrexone—CYP2D6—central nervous system—schizophrenia	0.000801	0.0119	CbGeAlD
Methylnaltrexone—CYP2D6—cerebellum—schizophrenia	0.000783	0.0117	CbGeAlD
Methylnaltrexone—Oxycodone—CYP2D6—schizophrenia	0.000732	0.0989	CrCbGaD
Methylnaltrexone—Buprenorphine—CYP2D6—schizophrenia	0.000675	0.0911	CrCbGaD
Methylnaltrexone—Hydromorphone—CYP2D6—schizophrenia	0.000665	0.0898	CrCbGaD
Methylnaltrexone—Naltrexone—ABCB1—schizophrenia	0.000656	0.0885	CrCbGaD
Methylnaltrexone—CYP2D6—brain—schizophrenia	0.000636	0.00948	CbGeAlD
Methylnaltrexone—Buprenorphine—ABCB1—schizophrenia	0.000482	0.065	CrCbGaD
Methylnaltrexone—Naloxone—ABCB1—schizophrenia	0.000478	0.0646	CrCbGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CHRM1—schizophrenia	0.000148	0.00146	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—CNR1—schizophrenia	0.000145	0.00143	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GRM3—schizophrenia	0.000145	0.00142	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—RGS4—schizophrenia	0.000145	0.00142	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—IL3RA—schizophrenia	0.000145	0.00142	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR6—schizophrenia	0.000142	0.0014	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—DRD2—schizophrenia	0.000142	0.0014	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—HTR7—schizophrenia	0.000142	0.0014	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCK—schizophrenia	0.000139	0.00137	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CHRM1—schizophrenia	0.000138	0.00136	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—GRM5—schizophrenia	0.000138	0.00136	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—CYP1A2—schizophrenia	0.000137	0.00135	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PPP1R1B—schizophrenia	0.000136	0.00134	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—PDE4B—schizophrenia	0.000135	0.00133	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—CYP1A2—schizophrenia	0.000135	0.00133	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—IL3RA—schizophrenia	0.000135	0.00132	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CCKAR—schizophrenia	0.000133	0.00131	CbGpPWpGaD
Methylnaltrexone—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	0.00013	0.00128	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—ADORA2A—schizophrenia	0.000129	0.00127	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—GRM5—schizophrenia	0.000128	0.00126	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FZD3—schizophrenia	0.000126	0.00124	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCK—schizophrenia	0.000126	0.00124	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DGKI—schizophrenia	0.000126	0.00124	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CHRM1—schizophrenia	0.000125	0.00123	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PDE4B—schizophrenia	0.000123	0.00121	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—IL3RA—schizophrenia	0.000122	0.0012	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CCKAR—schizophrenia	0.000121	0.00119	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—NPY—schizophrenia	0.000121	0.00119	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FES—schizophrenia	0.000119	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TAAR6—schizophrenia	0.000119	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GRM2—schizophrenia	0.000119	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PPP3CC—schizophrenia	0.000119	0.00117	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR ligand binding—HTR2A—schizophrenia	0.000117	0.00116	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCK—schizophrenia	0.000117	0.00116	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—ADORA2A—schizophrenia	0.000117	0.00115	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—GRM5—schizophrenia	0.000117	0.00115	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HTR1B—schizophrenia	0.000116	0.00115	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—OXT—schizophrenia	0.000116	0.00115	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—COMT—schizophrenia	0.000115	0.00113	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PPP1R1B—schizophrenia	0.000115	0.00113	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—GSTP1—schizophrenia	0.000114	0.00113	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—PDE4B—schizophrenia	0.000114	0.00113	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—MAOA—schizophrenia	0.000114	0.00112	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—COMT—schizophrenia	0.000113	0.00112	CbGpPWpGaD
Methylnaltrexone—OPRM1—TCR Signaling Pathway—AKT1—schizophrenia	0.000113	0.00111	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—GSTP1—schizophrenia	0.000113	0.00111	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CCKAR—schizophrenia	0.000113	0.00111	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HTR1A—schizophrenia	0.000112	0.0011	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—NPS—schizophrenia	0.00011	0.00109	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NGEF—schizophrenia	0.00011	0.00108	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—NPY—schizophrenia	0.00011	0.00108	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—ADORA2A—schizophrenia	0.000109	0.00107	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—DRD1—schizophrenia	0.000108	0.00107	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HTR2C—schizophrenia	0.000108	0.00107	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NTS—schizophrenia	0.000107	0.00106	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FZD3—schizophrenia	0.000107	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCK—schizophrenia	0.000107	0.00105	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HTR1B—schizophrenia	0.000106	0.00104	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—OXT—schizophrenia	0.000106	0.00104	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Biological oxidations—GSTM1—schizophrenia	0.000105	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—DRD3—schizophrenia	0.000105	0.00103	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PDE4B—schizophrenia	0.000104	0.00102	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metapathway biotransformation—GSTM1—schizophrenia	0.000104	0.00102	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CCKAR—schizophrenia	0.000102	0.00101	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—NPY—schizophrenia	0.000102	0.001	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HTR1A—schizophrenia	0.000102	0.001	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—DRD4—schizophrenia	0.000102	0.001	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RTN4—schizophrenia	0.000101	0.000995	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GRM3—schizophrenia	0.000101	0.000995	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—RGS4—schizophrenia	0.000101	0.000995	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FES—schizophrenia	0.0001	0.000989	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PPP3CC—schizophrenia	0.0001	0.000989	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GRM2—schizophrenia	0.0001	0.000989	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TAAR6—schizophrenia	0.0001	0.000989	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—NPS—schizophrenia	0.0001	0.000986	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR ligand binding—HTR2A—schizophrenia	9.93e-05	0.000977	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR6—schizophrenia	9.92e-05	0.000976	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—ADORA2A—schizophrenia	9.91e-05	0.000975	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HTR1B—schizophrenia	9.84e-05	0.000968	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—OXT—schizophrenia	9.84e-05	0.000968	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PRODH—schizophrenia	9.83e-05	0.000968	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HTR2C—schizophrenia	9.82e-05	0.000967	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—DRD1—schizophrenia	9.82e-05	0.000967	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—CNR1—schizophrenia	9.71e-05	0.000956	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MAG—schizophrenia	9.58e-05	0.000943	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—DRD3—schizophrenia	9.51e-05	0.000937	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—DRD2—schizophrenia	9.48e-05	0.000933	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HTR7—schizophrenia	9.48e-05	0.000933	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HTR1A—schizophrenia	9.47e-05	0.000932	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—NPS—schizophrenia	9.32e-05	0.000918	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NGEF—schizophrenia	9.29e-05	0.000915	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—NPY—schizophrenia	9.26e-05	0.000911	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—DRD4—schizophrenia	9.24e-05	0.000909	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—DRD1—schizophrenia	9.14e-05	0.0009	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HTR2C—schizophrenia	9.14e-05	0.0009	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NTS—schizophrenia	9.08e-05	0.000894	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR1B—schizophrenia	8.93e-05	0.000879	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—OXT—schizophrenia	8.93e-05	0.000879	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—DRD3—schizophrenia	8.86e-05	0.000872	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—CNR1—schizophrenia	8.82e-05	0.000868	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CHRM1—schizophrenia	8.76e-05	0.000862	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—DRD2—schizophrenia	8.6e-05	0.000847	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HTR7—schizophrenia	8.6e-05	0.000847	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR1A—schizophrenia	8.6e-05	0.000846	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—DRD4—schizophrenia	8.6e-05	0.000846	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GRM3—schizophrenia	8.54e-05	0.000841	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RGS4—schizophrenia	8.54e-05	0.000841	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—RTN4—schizophrenia	8.54e-05	0.000841	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—IL3RA—schizophrenia	8.54e-05	0.00084	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—NPS—schizophrenia	8.47e-05	0.000833	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR6—schizophrenia	8.38e-05	0.000825	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NRG3—schizophrenia	8.33e-05	0.00082	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TLE1—schizophrenia	8.33e-05	0.00082	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—DRD1—schizophrenia	8.3e-05	0.000817	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR2C—schizophrenia	8.3e-05	0.000817	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GFAP—schizophrenia	8.24e-05	0.000811	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—CNR1—schizophrenia	8.21e-05	0.000808	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GRM5—schizophrenia	8.14e-05	0.000802	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MAG—schizophrenia	8.1e-05	0.000797	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—DRD3—schizophrenia	8.04e-05	0.000792	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MPC2—schizophrenia	8.02e-05	0.000789	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HTR7—schizophrenia	8.01e-05	0.000788	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—DRD2—schizophrenia	8.01e-05	0.000788	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TLE3—schizophrenia	7.89e-05	0.000777	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—DRD4—schizophrenia	7.81e-05	0.000769	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—CNR1—schizophrenia	7.45e-05	0.000734	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PLCH2—schizophrenia	7.45e-05	0.000734	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCK—schizophrenia	7.45e-05	0.000733	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CHRM1—schizophrenia	7.4e-05	0.000729	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR7—schizophrenia	7.27e-05	0.000716	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—DRD2—schizophrenia	7.27e-05	0.000716	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PDE4B—schizophrenia	7.26e-05	0.000715	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—IL3RA—schizophrenia	7.22e-05	0.00071	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CCKAR—schizophrenia	7.14e-05	0.000703	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NRG3—schizophrenia	7.04e-05	0.000693	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TLE1—schizophrenia	7.04e-05	0.000693	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NDST3—schizophrenia	7.01e-05	0.00069	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GFAP—schizophrenia	6.96e-05	0.000685	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ADORA2A—schizophrenia	6.93e-05	0.000682	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GRM5—schizophrenia	6.88e-05	0.000678	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—PLA2G4A—schizophrenia	6.81e-05	0.00067	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TLE3—schizophrenia	6.67e-05	0.000656	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ACSL6—schizophrenia	6.64e-05	0.000654	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SLC27A5—schizophrenia	6.64e-05	0.000654	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—FGA—schizophrenia	6.64e-05	0.000654	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—HTR2A—schizophrenia	6.64e-05	0.000653	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NPY—schizophrenia	6.47e-05	0.000637	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NOTCH4—schizophrenia	6.47e-05	0.000637	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ATP2A2—schizophrenia	6.47e-05	0.000637	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—DAO—schizophrenia	6.34e-05	0.000624	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCK—schizophrenia	6.3e-05	0.00062	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR1B—schizophrenia	6.24e-05	0.000615	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—OXT—schizophrenia	6.24e-05	0.000615	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PDE4B—schizophrenia	6.14e-05	0.000604	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PNP—schizophrenia	6.07e-05	0.000598	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CCKAR—schizophrenia	6.04e-05	0.000594	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—HTR2A—schizophrenia	6.03e-05	0.000593	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR1A—schizophrenia	6.01e-05	0.000592	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NPS—schizophrenia	5.92e-05	0.000583	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ADORA2A—schizophrenia	5.85e-05	0.000576	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR2C—schizophrenia	5.8e-05	0.000571	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—DRD1—schizophrenia	5.8e-05	0.000571	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—PLA2G4A—schizophrenia	5.76e-05	0.000567	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—NDUFV2—schizophrenia	5.65e-05	0.000556	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NTRK2—schizophrenia	5.65e-05	0.000556	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—DRD3—schizophrenia	5.62e-05	0.000553	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—FGA—schizophrenia	5.61e-05	0.000552	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—HTR2A—schizophrenia	5.61e-05	0.000552	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NPY—schizophrenia	5.47e-05	0.000538	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NOTCH4—schizophrenia	5.47e-05	0.000538	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ATP2A2—schizophrenia	5.47e-05	0.000538	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—DRD4—schizophrenia	5.46e-05	0.000537	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PIP4K2A—schizophrenia	5.31e-05	0.000523	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—OXT—schizophrenia	5.28e-05	0.000519	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR1B—schizophrenia	5.28e-05	0.000519	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—CNR1—schizophrenia	5.21e-05	0.000513	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—HTR2A—schizophrenia	5.09e-05	0.000501	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR7—schizophrenia	5.08e-05	0.0005	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—DRD2—schizophrenia	5.08e-05	0.0005	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR1A—schizophrenia	5.08e-05	0.0005	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NPS—schizophrenia	5e-05	0.000492	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR2C—schizophrenia	4.9e-05	0.000483	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DRD1—schizophrenia	4.9e-05	0.000483	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP26B1—schizophrenia	4.8e-05	0.000473	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PRL—schizophrenia	4.8e-05	0.000473	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NTRK2—schizophrenia	4.77e-05	0.00047	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DRD3—schizophrenia	4.75e-05	0.000468	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DRD4—schizophrenia	4.61e-05	0.000454	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—S100B—schizophrenia	4.47e-05	0.00044	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—CNR1—schizophrenia	4.4e-05	0.000433	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—DRD2—schizophrenia	4.3e-05	0.000423	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR7—schizophrenia	4.3e-05	0.000423	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TPH1—schizophrenia	4.28e-05	0.000421	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GCLM—schizophrenia	4.28e-05	0.000421	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ERBB4—schizophrenia	4.28e-05	0.000421	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PRL—schizophrenia	4.06e-05	0.000399	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PRKD1—schizophrenia	4.02e-05	0.000396	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—PLA2G4A—schizophrenia	4.02e-05	0.000396	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—NRG1—schizophrenia	3.95e-05	0.000389	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—MEF2C—schizophrenia	3.91e-05	0.000385	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—YWHAZ—schizophrenia	3.78e-05	0.000372	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—S100B—schizophrenia	3.78e-05	0.000372	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ERBB3—schizophrenia	3.7e-05	0.000364	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ERBB4—schizophrenia	3.62e-05	0.000356	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—HTR2A—schizophrenia	3.56e-05	0.00035	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—PLA2G4A—schizophrenia	3.4e-05	0.000335	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GAPDH—schizophrenia	3.36e-05	0.000331	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—NRG1—schizophrenia	3.34e-05	0.000329	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CLOCK—schizophrenia	3.33e-05	0.000328	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—APOE—schizophrenia	3.31e-05	0.000326	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—MEF2C—schizophrenia	3.31e-05	0.000326	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—APOA1—schizophrenia	3.27e-05	0.000322	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TPH2—schizophrenia	3.24e-05	0.000319	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CACNB2—schizophrenia	3.24e-05	0.000319	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—YWHAZ—schizophrenia	3.2e-05	0.000315	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—DPYD—schizophrenia	3.19e-05	0.000314	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—ESR1—schizophrenia	3.16e-05	0.000311	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ERBB3—schizophrenia	3.13e-05	0.000308	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—HTR2A—schizophrenia	3.01e-05	0.000296	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CACNA1C—schizophrenia	2.97e-05	0.000292	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PIK3C2A—schizophrenia	2.89e-05	0.000285	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—GSK3B—schizophrenia	2.87e-05	0.000282	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—APOE—schizophrenia	2.8e-05	0.000275	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—APOA1—schizophrenia	2.77e-05	0.000272	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—ESR1—schizophrenia	2.67e-05	0.000263	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—SNAP25—schizophrenia	2.59e-05	0.000255	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—GSK3B—schizophrenia	2.42e-05	0.000238	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—CYP1A2—schizophrenia	2.35e-05	0.000231	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—TH—schizophrenia	2.31e-05	0.000228	CbGpPWpGaD
Methylnaltrexone—OPRK1—GPCR downstream signaling—AKT1—schizophrenia	2.12e-05	0.000209	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—COMT—schizophrenia	1.97e-05	0.000193	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTP1—schizophrenia	1.96e-05	0.000193	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MAOA—schizophrenia	1.95e-05	0.000192	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling by GPCR—AKT1—schizophrenia	1.93e-05	0.00019	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—EP300—schizophrenia	1.89e-05	0.000186	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—ABCB1—schizophrenia	1.85e-05	0.000182	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—PLA2G4A—schizophrenia	1.8e-05	0.000177	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—GSTM1—schizophrenia	1.8e-05	0.000177	CbGpPWpGaD
Methylnaltrexone—OPRM1—GPCR downstream signaling—AKT1—schizophrenia	1.8e-05	0.000177	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling by GPCR—AKT1—schizophrenia	1.63e-05	0.000161	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—EP300—schizophrenia	1.59e-05	0.000157	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—MTHFR—schizophrenia	1.59e-05	0.000156	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—APOE—schizophrenia	1.48e-05	0.000146	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—APOA1—schizophrenia	1.46e-05	0.000144	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—TP53—schizophrenia	1.35e-05	0.000133	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—TP53—schizophrenia	1.14e-05	0.000112	CbGpPWpGaD
Methylnaltrexone—OPRK1—Signaling Pathways—AKT1—schizophrenia	1.14e-05	0.000112	CbGpPWpGaD
Methylnaltrexone—OPRM1—Signaling Pathways—AKT1—schizophrenia	9.63e-06	9.48e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—EP300—schizophrenia	8.43e-06	8.3e-05	CbGpPWpGaD
Methylnaltrexone—CYP2D6—Metabolism—AKT1—schizophrenia	5.09e-06	5.01e-05	CbGpPWpGaD
